系统性硬化症相关肺动脉高压的血浆循环microRNA研究
结果显示miR-20a-5p和miR-203a-3p在两组间差异有统计学意义,且与NT-proBNP水平呈负相关,提示循环miRNA可能与SSc相关肺动脉高压的发生相关。
要点
- 在ACA阳性lcSSc女性患者中,miR-20a-5p和miR-203a-3p血浆水平与SSc-APAH存在关联。
- miR-21-5p和miR-20a-5p单独或联合的ROC曲线AUC为0.69–0.83。
- 纵向分析未能识别任何miRNA作为PAH发生的预测因子。
核心结论
- 研究将循环血浆miRNA尤其是miR-20a-5p和miR-203a-3p的表达水平与ACA阳性lcSSc女性患者中SSc-APAH的发生相关联。
主要发现
- SSc-APAH患者病程12年,SSc对照病程12.7年。
- 11种miRNA在SSc-APAH患者中血浆表达水平较低,4种miRNA在SSc-APAH患者中血浆水平高于SSc对照。
- 多重比较校正后,miR-20a-5p和miR-203a-3p在组间差异有统计学意义(两者P=0.002)。
- ROC曲线显示miR-21-5p和miR-20a-5p单独或联合的AUC=0.69–0.83。
- miR-20a-5p和miR-203a-3p与NT-pro-Brain Natriuretic Protein水平呈负相关(r=-0.42和-0.47)。
临床怎么用
- 在ACA阳性lcSSc女性患者中,可关注血浆miR-20a-5p和miR-203a-3p水平与SSc-APAH的关联,但其临床作为诊断或预测工具的价值尚未确立。
局限性
- 混合效应模型分析未能识别任何miRNA作为PAH发生的预测因子,纵向预测价值有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: SSc-associated pulmonary arterial hypertension (SSc-APAH) is a late but devastating complication of SSc. Early identification of SSc-APAH may improve survival. We examined the role of circulating miRNAs in SSc-APAH. METHODS: Using quantitative RT-PCR the abundance of mature miRNAs in plasma was determined in 85 female patients with ACA-positive lcSSc. Twenty-two of the patients had SSc-APAH. Sixty-three SSc controls without PAH were matched for disease duration. Forty-six selected miRNA plasma levels were correlated with clinical data. Longitudinal samples were analysed from 14 SSc-APAH and 27 SSc patients. RESULTS: The disease duration was 12 years for the SSc-APAH patients and 12.7 years for the SSc controls. Plasma expression levels of 11 miRNAs were lower in patients with SSc-APAH. Four miRNAs displayed higher plasma levels in SSc-APAH patients compared with SSc controls. There was significant difference between groups for miR-20a-5p and miR-203a-3p when correcting for multiple comparisons (P = 0.002 for both). Receiver operating characteristics curve showed AUC = 0.69-0.83 for miR-21-5p and miR-20a-5p or their combination. miR-20a-5p and miR-203a-3p correlated inversely with NT-pro-Brain Natriuretic Protein levels (r = -0.42 and -0.47). Mixed effect model analysis could not identify any miRNAs as predictor of PAH development. However, miR-20a-5p plasma levels were lower in the longitudinal samples of SSc-APAH patients than in the SSc controls. CONCLUSIONS: Our study links expression levels of the circulating plasma miRNAs, especially miR-20a-5p and miR-203a-3p, to the occurrence of SSc-APAH in female patients with ACA-positive lcSSc.
引用
- Wuttge DM, Carlsen AL, Teku G, et al. Circulating plasma microRNAs in systemic sclerosis-associated pulmonary arterial hypertension. Rheumatology (Oxford). 2021. PMID: 33784391. doi:10.1093/rheumatology/keab300
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。